Detalhe da pesquisa
1.
The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study.
BMC Cancer
; 24(1): 164, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38302968
2.
Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti-PD-1-Based Immunotherapy as Curative-Intent Treatment.
J Natl Compr Canc Netw
; 22(3)2024 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498975
3.
Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair-Deficient Colorectal Cancer.
J Natl Compr Canc Netw
; 21(1): 60-66.e5, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630898
4.
Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Dis Colon Rectum
; 66(10): e996-e1005, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485833
5.
Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel.
J Med Genet
; 59(4): 370-376, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563768
6.
Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review.
Clin Colon Rectal Surg
; 36(6): 378-384, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795463
7.
Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer.
Cancer Cell Int
; 21(1): 554, 2021 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688293
8.
Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study.
BMC Cancer
; 19(1): 1210, 2019 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31830954
9.
Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Mol Cancer
; 16(1): 158, 2017 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29025423
10.
DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer.
Clin Transl Oncol
; 25(1): 218-225, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36076121
11.
Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients.
Eur J Cancer
; 192: 113253, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625240
12.
A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions.
Cancer Med
; 12(21): 20626-20638, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881109
13.
Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study.
Front Pharmacol
; 13: 950101, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36238544
14.
B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy.
J Immunother
; 45(4): 187-193, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35343934
15.
Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer.
Nat Commun
; 13(1): 7316, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36443332
16.
Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study.
Eur J Cancer
; 174: 176-184, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030556
17.
RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases.
Pathol Oncol Res
; 27: 1610077, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34924821
18.
Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.
Cancer Lett
; 500: 119-131, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338532
19.
Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer.
J Immunother Cancer
; 9(3)2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782107
20.
Serum Gamma Glutamyl transferase is a predictor of recurrence after R0 hepatectomy for patients with colorectal cancer liver metastases.
Ther Adv Med Oncol
; 12: 1758835920947971, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32913447